Prevotella melaninogenica disrupted oral epithelial barrier function via myosin light chain kinase

Yiting Guo1, Wenhao Han2, Yuan He1

  • 1Department of Oral Medicine, Stomatology Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China.

Oral Diseases
|May 9, 2024
PubMed
Abstract

Insights

Prevotella melaninogenica (Pm) increases oral keratinocyte permeability and disrupts the epithelial barrier by upregulating myosin light chain kinase (MLCK). Inhibiting MLCK restores barrier function, suggesting a role for Pm in oral lichen planus pathogenesis.

Area of Science:

  • Oral microbiology
  • Epithelial biology
  • Immunodermatology

Background:

  • Oral lichen planus (OLP) is associated with increased Prevotella melaninogenica (Pm) on the buccal mucosa.
  • Pm has the ability to invade the epithelium of OLP patients.
  • The specific impact of Pm on oral keratinocytes remains to be fully elucidated.

Purpose of the Study:

  • To investigate the effects of Prevotella melaninogenica (Pm) on human oral keratinocytes (HOKs).
  • To identify molecular mechanisms underlying Pm-induced epithelial barrier dysfunction.
  • To explore the potential role of myosin light chain kinase (MLCK) in this process.

Main Methods:

  • Established a co-culture model of Pm and HOKs.
  • Assessed HOK monolayer permeability and zona occludens-1 (ZO-1) expression.
  • Utilized RNA-sequencing (RNA-seq) to identify differentially expressed genes (DEGs), focusing on MLCK.
  • Administered an MLCK inhibitor (ML-7) to evaluate its impact on epithelial barrier function.

Main Results:

  • Co-culture with Pm increased HOK monolayer permeability and decreased ZO-1 expression.
  • Pm demonstrated intracellular survival within HOKs.
  • RNA-seq identified MLCK as a significantly upregulated DEG in the Pm-HOK model.
  • MLCK inhibition reversed the increased permeability and restored ZO-1 expression.

Conclusions:

  • Prevotella melaninogenica (Pm) disrupts the oral epithelial barrier function.
  • Myosin light chain kinase (MLCK) is implicated in Pm-mediated epithelial barrier disruption.
  • Targeting MLCK may offer a therapeutic strategy for OLP by restoring epithelial integrity.